1. Market Research
  2. > Pathology
Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

About 7000 reports for Lymphoma (page 7)

Purchase Reports From Reputable Market Research Publishers

Transthyretin Amyloidosis - Global Drug Forecast and Market Analysis to 2029

  • $ 10995
  • June 2020
  • 129 pages

AMYLOIDOSIS MAY APPEAR IN CONJUNCTION WITH OR AS A RESULT OF THE FOLLOWING DISORDERS: MULTIPLE MYELOMA, HODGKIN' S LYMPHOMA, LYMPHOMA, MEDULLARY CARCINOMA OF THE THYROID, WHIPPLE DISEASE, CROHN' S DISEASE, OSTEOMYELITIS, RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, REITER NATIONAL

  • Antimalarials
  • Endocrine Disease
  • Lymphoma
  • Pathology
  • Pfizer Inc.

Multiple Myeloma: Epidemiology Forecast to 2027

  • $ 3995
  • March 2019
  • 42 pages

The Leukemia and Lymphoma Society (2015) Myeloma.

  • Cancer
  • Lymphoma
  • Japan
  • United States
  • Forecast

Global Seed Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)

  • $ 950
  • April 2020
  • 98 pages

lymphoma, solid tumors with NTRK gene fusions Nexavar, Nubeqa, Xofigo, Stivarga, Aliqopa, Vitrakvi Ophthalmology Visual impairment due to agerelated macular degeneration (AMD), diabetic macular edema (DME) or retinal vein occlusion (RVO) Eylea Hematology Hemophilia A Kogenate/ Kovaltry

  • Agricultural Products
  • Lymphoma
  • World
  • BASF SE
  • Bayer AG

Global Big Pharma Partnering Terms and Agreements 2014-2020: Deal trends, players and financials

  • $ 3495
  • March 2020
  • 1800 pages

Lymphoma Society, Lexicon Pharmaceuticals, Lieber Institute, LifeArc, LifeMax Laboratories, Ligand Pharmaceuticals, Lilly Endowment, Lincoln Equities Group, Lipigon Pharmaceuticals, Litha Pharma, Liverpool School of Tropical Medicine, Living Proof, Livongo Health, LLamasoft, Locemia Solutio

  • Biopharmaceutical
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • United States

Chronic Lymphocytic Leukemia - Competitive Landscape to 2030

  • $ 3495
  • May 2020
  • 55 pages

Lung Cancer Breast Cancer Leukemia Lymphoma Non-Small Cell Lung...

  • Leukemia
  • Lymphoma
  • AbbVie Inc.
  • AstraZeneca PLC
  • Roche Group

Peripheral T-Cell Lymphoma Epidemiology Forecast to 2030

  • $ 3750
  • July 2020
  • 100 pages

Anaplastic Large Cell Lymphoma (ALCL) ##. ##. ##.

  • Cancer
  • Lymphoma
  • Pathology
  • Germany
  • United States

Global Cancer Immunotherapy Market to 2027

  • $ 4468
  • December 2017
  • 165 pages

Global Cancer Immunotherapy Market for Other Cancer types (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma), ($m, AGR%, CAGR%) 2016-2027 Table ##. ##.

  • Cancer Immunotherapy
  • Lymphoma
  • Therapy
  • World
  • Market Size

Systemic Lupus Erythematosus and Lupus Nephritis: Global Drug Forecast and Market Analysis to 2027

  • $ 10995
  • February 2020
  • 163 pages

R. (2016) ' B CELLS GONE ROGUE: THE INTERSECTION OF DIFFUSE LARGE B CELL LYMPHOMA AND AUTOIMMUNE DISEASE', EXPERT REVIEW OF HEMATOLOGY, ##(##), PP. ##-##.

  • Genitourinary System Disease
  • Hospital
  • Lymphoma
  • Musculoskeletal Disorder
  • Therapy

Non-Hodgkin Lymphoma Treatment Market.: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • $ 4795
  • June 2019
  • 100 pages

Non-Hodgkin Lymphoma Treatment Market. : Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025 ##.

  • Cancer
  • Lymphoma
  • World
  • Market Size

Global Market Study on CAR T-cell Therapy: The Future of Cancer Treatment

  • $ 4900
  • November 2019
  • 150 pages

Relapsed Large B-cell Lymphoma ##. ##. ##.

  • Biopharmaceutical
  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Market Size

Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Route of Administration ; Application ; End User, and Geography

  • $ 4550
  • May 2020
  • 197 pages

Pfizer Inc. has received the European Commission (EC) for its Lorviqua for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced nonsmall cell lung cancer (NSCLC).

  • Lymphoma
  • Pharmaceutical
  • United States
  • Forecast
  • Market Size

Antibody Drugs: Technologies and Global Markets

  • $ 5500
  • September 2017
  • 115 pages

• The global antibody drugs market for lymphoma reached $##. ## billion in 2016.

  • Lymphoma
  • Medical Biotechnology
  • Monoclonal Antibody
  • World
  • Market Shares

Burkitt Lymphoma Global Clinical Trials Review, H1, 2020

  • $ 2500
  • February 2020
  • 311 pages

Burkitt Lymphoma Global Clinical Trials Review, H##, 2020 H e a l t h c a r e H e a l t h c a r e REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: FEB 2020 LIST OF TABLES LIST OF FIGURES Burkitt Lymphoma Global Clinical Trials Review, H##, 2020 outlines clinical trials in Burkitt

  • Clinical Trial
  • Immunotherapy
  • Lymphoma
  • Monoclonal Antibody
  • Therapy

GLOBAL STEM CELL TECHNOLOGIES AND APPLICATIONS MARKET 2018-2028

  • $ 4468
  • March 2018
  • 284 pages

Estimated New Cases of Leukemia, Lymphoma and Myeloma in 2017 Figure ##. ##.

  • Cell Therapy
  • Lymphoma
  • Medical Biotechnology
  • World

Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2014- 2020

  • $ 3495
  • March 2020
  • 1500 pages

Lymphoma Society, LexaGene, Lexogen, LGC, LG Life Sciences, Lhasa, Lieber Institute, LifeArc, LifeMap Sciences, Ligand Pharmaceuticals, Li Ka Shing Foundation, Lineage Cell Therapeutics, LineaRx, LipimetiX Development, Lipotype, Liverpool School of Tropical Medicine, Livongo Health, LNC, Lo

  • Biotechnology
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • United States

B-Cell Non-Hodgkin’s Lymphoma (NHL): Opportunity Analysis and Forecasts to 2027

  • $ 10995
  • June 2019
  • 147 pages

The faster-growing, more aggressive B-cell lymphomas are referred to as high-grade lymphomas, and include DLBCL, MCL, primary mediastinal large B-cell lymphoma, follicular large-cell lymphoma, and intravascular large B-cell lymphoma.

  • Cancer
  • Immunotherapy
  • Lymphoma
  • Therapy
  • United States

Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030

  • $ 4499
  • April 2019
  • 372 pages

Lymphoma: Number of Trials and Affiliated Biomarkers Please contact our Customer Support Center to get the complete Table of Contents INTRODUCTION Over the last couple of decades, the healthcare market has witnessed the entry of several advanced and effective treatment options for cancer; t

  • Biomarker
  • Biotechnology
  • Genomics Proteomics And Enabling Technology
  • Lymphoma

Gazyva

  • $ 10000
  • January 2019
  • 40 pages

Gazyva CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Gazyva : Chronic lymphocytic leukemia (CLL) ## Gazyva : NHL: Follicular lymphoma (FL) ## Gazyva : NHL: Mantle cell lymphoma (MCL) LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of

  • Biopharmaceutical
  • Lymphoma
  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy

Imbruvica

  • $ 10000
  • January 2019
  • 51 pages

Imbruvica CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Imbruvica : Chronic lymphocytic leukemia (CLL) ## Imbruvica : NHL: Follicular lymphoma (FL) ## Imbruvica : NHL: Diffuse large B-cell lymphoma (DLBCL) ## Imbruvica : NHL: Mantle cell lymphoma (MCL) L

  • Cancer
  • Lymphoma
  • Pathology
  • Therapy
  • European Union

Kymriah

  • $ 10000
  • January 2019
  • 38 pages

Kymriah CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Kymriah : Chronic lymphocytic leukemia (CLL) ## Kymriah : NHL: Follicular lymphoma (FL) ## Kymriah : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessm

  • Cancer
  • Lymphoma
  • Medical Biotechnology
  • Pathology
  • European Union
View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on